SCHEMBL19706156

SCHEMBL19706156

CCN1CCCN(C(=O)Nc2ccc(F)cn2)c2nc(-c3ccnc(N4CCC(C(F)(F)F)C4)c3)ccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FGFR4 P22455 4/20 0.38
▸ SLC34A1 Q06495 1/20 0.35
▸ KARS1 Q15046 2/20 0.34
▸ HCRTR1 O43613 2/20 0.34
▸ MAP3K12 Q12852 1/20 0.34
▸ FAAH O00519 1/20 0.34
▸ SCN10A Q9Y5Y9 1/20 0.33
▸ SCD O00767 1/20 0.33
▸ WNT1 P04628 1/20 0.33
▸ GSK3B P49841 1/20 0.33
▸ DYRK1A Q13627 1/20 0.33
▸ CLK2 P49760 2/20 0.32
▸ LRRK2 Q5S007 2/20 0.32
▸ RAF1 P04049 1/20 0.32
▸ KCNH2 Q12809 1/20 0.32
▸ SCN5A Q14524 1/20 0.32
▸ ITGB2 P05107 1/20 0.32
▸ ICAM1 P05362 1/20 0.32
▸ ITGAL P20701 1/20 0.32
▸ NPY5R Q15761 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19670311 0.91 FGFR4 (0.37) FGFR4SLC34A1KARS1HCRTR1MAP3K12
SCHEMBL19706164 0.85 FGFR4 (0.40) FGFR4HCRTR1SCN10A
SCHEMBL16776128 0.85 FGFR4 (0.38) FGFR4SLC34A1KARS1HCRTR1MAP3K12
SCHEMBL19365456 0.84 FGFR4 (0.39) FGFR4KARS1HCRTR1SCDDYRK1A
SCHEMBL19365564 0.84 FGFR4 (0.39) FGFR4KARS1HCRTR1SCDDYRK1A
SCHEMBL16238200 0.82 SCD (0.37) SLC34A1KARS1MAP3K12FAAHSCN10A
SCHEMBL19669950 0.81 KARS1 (0.34) FGFR4KARS1HCRTR1FAAHSCD
SCHEMBL19669954 0.81 KARS1 (0.34) FGFR4KARS1HCRTR1FAAHSCD
SCHEMBL19670490 0.81 SLC34A1 (0.36) SLC34A1KARS1HCRTR1MAP3K12FAAH
SCHEMBL19670545 0.80 FGFR4 (0.40) FGFR4MAP3K12FAAHSCN10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10590135-B2 Substituted bridged urea analogs as sirtuin modulators GLAXOSMITHKLINE LLC (US) 2020-03-17 — — US disclosed
US-20170355697-A1 SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS GLAXOSMITHKLINE LLC 2017-12-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170355697-A1 SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS SIRT1, SIRT3, SIRT2 FGFR4 1754/4885SLC34A1 3135/4885KARS1 1760/4885
US-10590135-B2 Substituted bridged urea analogs as sirtuin modulators SIRT1, SIRT3, SIRT2 FGFR4 1754/4885SLC34A1 3135/4885KARS1 1760/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback